Senior insider sale
Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$202.0K
6.99K shares
What this filing means
GHEUENS SARAH plans to sell 6.99K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $202.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001439222-26-000028
Officer· Chief Medical Officer
Since Sep 2021
6.99K
Shares to sell
$202.0K
Approx. market value
4.05K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
3/2/2026
4.05KTotal acquired4.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Vesting of Restricted Stock Units Not Applicable | 4.05K | — |
| Total | 4.05K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.93K
Market value
$79.4K
12/30/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.05K
Market value
$122.6K
3/2/2026
Total
Units
6.99K
Value
$202.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/30/2025 | 2.93K | $79.4K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 4.05K | $122.6K | Nasdaq | Planned |
| Total | 6.99K | $202.0K | ||